This month includes a careful examination of donor-derived cell-free DNA with a meta-analysis, an overview, and a commentary, all of serve to highlight the real progress and separate that from the hype surrounding this biomarker. We publish the next in the series of ILTS consensus statements - on DCD complications. The liver community will also read with interest the analysis of the Liver kidney safety net and also the circumstances where pretransplant bariatric surgery does not impact liver transplant outcomes. The kidney teams continue to combat ABMR and peripheral vascular disease, both of which are reviewed in detail. Teenage adherence and mental health of living kidney donors are also addressed as are many other subjects including heart and lung transplant issues.
CLICK HERE TO ACCESS THIS ISSUE
TTS MEMBERS - CLICK HERE TO SIGN-IN FOR OPEN ACCESS THROUGH TTS.ORG